Choice of cancer vaccine is branded a missed opportunity by charities

Kmietowicz, Zosia
June 2008
BMJ: British Medical Journal (International Edition);6/28/2008, Vol. 336 Issue 7659, p1456
Academic Journal
The article discusses how health charities are criticizing the adoption of the drug Cervarix into national immunisation initiatives in Great Britain. Cervarix, developed by the pharmaceutical firm GlaxoSmithKline is designed to vaccinate women against human papillomaviruses, which can cause cervical cancer. Charities have suggested that the drug Gardasil has the ability to protect women from a greater variety of human papillomaviruses.


Related Articles

  • Formative research to shape HPV vaccine introduction strategies in Peru. Bartolini, Rosario M.; Drake, Jennifer Kidwell; Creed-Kanashiro, Hilary M.; Díaz-Otoya, Margarita M.; Mosqueira-Lovón, Nelly Rocío; Penny, Mary E.; Winkler, Jennifer L.; LaMontagne, Scott; Bingham, Allison // Salud Pública de México;may2010, Vol. 52 Issue 3, p226 

    Objetivo. Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones políticas vinculadas al cáncer cervical y a la vacuna contra el VPH para diseñar una estrategia apropiada de introducción de la vacuna contra el VPH. Material y métodos....

  • HPV vaccine strategies: the cost of HPV and the choice of vaccine. Morris, Sheldon R. // Sexually Transmitted Infections;Sep2009, Vol. 85 Issue 5, p315 

    The author reflects on the strategies for selecting the right human papillomavirus (HPV) vaccines for the prevention of cervical cancer. He cites efficacious vaccines that are approved in many developed countries which include Merck quadrivalent HPV 6/11/16/18 (Gardisil) and GSK bivalent HPV...

  • HPV test would enhance screening.  // Practice Nurse;12/19/2003, Vol. 26 Issue 10, p6 

    Focuses on the human papilloma virus (HPV) test for the prevention of cervical cancer. Comparison between HPV and smear tests; Percentage of cervical abnormalities detected by the HPV test in women aged 30 to 60 years old; Effect of the test on the immune system.

  • Response to The HPV Vaccination Campaign: A Project of Moral Regulation in an Era of Biopolitics. MACDONALD, LIANE; DEEKS, SHELLEY; DOYLE, CAROLYN // Canadian Journal of Sociology;Fall2010, Vol. 35 Issue 4, p627 

    In this article the authors discuss the Canadian public health campaign regarding the human papillomavirus (HPV) vaccination used for the prevention of cervical cancer. They argue that a voluntary program in schools could provide access to the HPV vaccination for low-income and Aboriginal women,...

  • HPV vaccine holds promise of wiping out cervical cancer--but many problems remain. Foxhall, Kathryn // Contemporary Pediatrics;Dec2006, Vol. 23 Issue 12, p14 

    The article discusses barriers to eliminating cervical cancer in the U.S. using the human papillomavirus (HPV) vaccine Gardasil. According to Juan Felix, professor of obstetrics and gynecology at the University of Southern California, social and cultural issues present barriers towards...

  • A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Brabin, L.; Roberts, S. A.; Stretch, R.; Baxter, D.; Elton, P.; Kitchener, H.; McCann, R. // British Journal of Cancer;11/3/2009, Vol. 101 Issue 9, p1502 

    Background:There is little information on girls' experiences of human papillomavirus (HPV) vaccination in the prevention of cervical cancer. We investigated the views of adolescent girls who had been offered the vaccine as part of a feasibility study conducted in Manchester.Methods:All 12 to...

  • VACCINATION AGAINST THE HPV POSSIBLE PRIMARY PREVENTION FOR NEOPLASIA. Ioan, Raluca Gabriela; Dincă, Gabriela Adriana; Ionescu, Mioara // Romanian Journal of Pediatrics;2013, Vol. 62 Issue 4, p355 

    The frequency of different types of cancer (among which the cervical cancer covers 55%) etiologically correlated with the Human Papillomavirus (HPV) infection is worrying particularly amongst early ages. Demonstrating the presence and the oncogene role of some HPV types opened the way to...

  • Consenso para la prevención del cáncer cervicouterino en México. Kably Ambe, Alberto; Antonio Ruiz Moreno, José; Lazcano Ponce, Eduardo; Manuel Vargas Hernández, Víctor; A. Aguado Pérez, Rogelio; Alonso de Ruiz, Patricia // Ginecologia y Obstetricia de Mexico;dic2011, Vol. 79 Issue 12, p785 

    Cervical cancer remains a serious public health problem in the world; that is why the Mexican Federation of Schools of Obstetrics and Gynecology convened the elaboration of a consensus that is devoted this number of Ginecología y Obstetricia de México. In recent years has strengthened...

  • Women in the dark on cervical cancer facts.  // Contraceptive Technology Update;Apr2008, Vol. 29 Issue 4, p48 

    The article focuses on a new survey by the National Association of Nurse Practitioners in Women's Health (NPWH) which shows that most women are confused myth with fact about cervical cancer prevention.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics